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Background: Investigations of molecular mechanisms behind the progression of neoplastic changes in the
esophagus have uncovered the role of the COX & 5-Lox pathways. Human squamous esophageal mucosa
produces relatively large amounts of eicosanoids in the presence of inﬂammation. Laboratory and
epidemiological data suggest that aspirin and non-steroidal anti-inﬂammatory drugs may be chemo
preventive through their inhibitory effect on COX25, 10. Cell culture studies have shown that the
members of the mitogen activated protein (MAP) kinase family plays an important role in the devel-
opment of bile acid-induced carcinogenesis. Differences in MAPK pathways activated by bile exposure
were also noted in esophageal squamous cell lines and biopsies from patients with GERD. The protective
role of aspirin and its molecular mechanism is not well understood.
Aims:
1. The effect of duodenal reﬂux on esophageal mucosa.
2. The role of aspirin in preventing duodenal reﬂux induced esophageal mucosa changes.
3. If it is proven to be preventive, the mechanism of its action. A duodenal reﬂux rat animal model was
used by an end- to-side esophago duodenostomy.
Methods: Total of 56 rats was included. 3 were "Naive control" animals which did not undergo the
surgical procedure. The remaining animals were divided into two groups: Surgery alone (experimental)
and Surgery þ aspirin [therapy group], esophagoduodenostomy. At 40 weeks, the rats were euthanized
and appropriate esophageal samples were analysed for histopathology and p38 & ERK MAP kinases,
VEGF, protease activity and caspase 3 activities.
Results: The presence of gross mucosal nodularity was seen in 21 and 10 rats of the experimental and
therapy group respectively (p ¼ 0.03; Table 1). Reﬂux-associated changes such as basal cell hyperplasia
were more common in the experimental group, however this association did not reach statistical
signiﬁcance (p ¼ 0.15; Table 1). Epithelial hyperplasia was seen more in the experimental group, which
was prevented by aspirin [p < 0.01]. Papillomatosis, as shown in Fig. 4 was more common in the
experimental group (p ¼ 0.02). Activation of p38 & ERK MAP kinases was prevented in aspirin group
(p < 0.05, CI 1.796e0.014). Examination of protease activity by zymographic analysis of the esoph-
ageal samples revealed a number of gelatinolytic bands in 50% rats of the experimental group, not
observed in the therapy group. No signiﬁcant changes were seen in Caspase 3 [Normal areas 99.74 &
nodular areas e 100.34 percent of controls] or VEGF [mean 0.64, sd  0.76 Vs 0.69  0.96] activity.
Conclusions: Our data demonstrated that low dose aspirin reduced the incidence of duodenoesophageal
reﬂux induced histological changes in the esophagus by preventing activation of proliferative & anti-
apoptotic MAP kinases such as p38 & ER as well as protease activity. Though Barretts’ changes and215 300 1493; fax: 91 0416
ciates Ltd. Published by Elsevier Ltd. All rights reserved.
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development of different histological but potential premalignant lesions and molecular level changes
which are prevented by low dose aspirin.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Esophageal squamous cell carcinoma is one of themost frequent
malignancies worldwide.1 It progresses through stages such as
dysplasia, carcinoma in situ and then it becomes invasive carci-
noma. In the development of disease, the common link between
the dietary and environmental factors is a chronic inﬂammatory
state which is associated with increased turnover of cells.2 A
signiﬁcantly higher incidence of squamous cell carcinoma & pre-
neoplastic disease of the larynx & pharynx was seen in patients
undergoing Billroth II and total gastrectomy than Billroth I and
Roux-en-Y resection3; the prevalence of histological esophageal
papilloma or squamous cancer has shown to be increased in rats
with combination of pancreatic and bile reﬂux.4 A number of
substances in duodenal reﬂuxate such as lysolecithin, trypsin and
secondary bile acids are possible co-carcinogens.5
Investigations of molecular mechanisms behind the progression
of neoplastic changes in the esophagushaveuncovered the role of the
COX & 5-Lox pathways. Human squamous esophageal mucosa
produces relatively large amounts of eicosanoids in the presence of
inﬂammation.6,7 Treatment with Omeprazole for GERD reduced the
production of PGE2 and LTB4.8,9 Laboratory and epidemiological data
suggest that aspirin and non-steroidal anti-inﬂammatory drugs may
be chemo preventive through their inhibitory effect on COX2.5,10
Pooled results from human studies also support a protective associ-
ation between aspirin and NSAID and esophageal cancer (of both
histological types), and therefore provide evidence for a dose effect.11
Cell culture studies have shown that the members of the
mitogen activated protein (MAP) kinase family plays an important
role in the development of bile acid-induced carcinogenesis.
Differences in MAPK pathways activated by bile exposurewere also
noted in esophageal squamous cell lines and biopsies from patients
with GERD.12 Considerable evidence exists to indicate that matrix
metalloproteinases (MMPs) have an important role in tumor
invasion and tumor spread.13e16 Over expression of both MMP-2
and MMP-9 have been shown to be associated with esophageal
squamous cell carcinoma.17 VEGF has been associated with
aggressive characteristics of esophageal squamous cell carcinoma,
therefore possibly correlating with tumor stage, positive lymph
nodes and patient outcome.37Fig. 1. Esophago duodenal anastomosis. An enterotomy was made 3 cm distal to the
pylorus on the anti-mesenteric border. The distal esophagus was then anastomosed to
the duodenal enterotomy with accurate mucosal to mucosal opposition.2. Aim
1. The effect of duodenal reﬂux on esophageal mucosa
2. The role of aspirin in preventing duodenal reﬂux induced
esophageal mucosa changes.
3. Mechanism by which aspirin exerts its preventive action.
Duodenal reﬂux animal model was created by an end- to-side
esophago duodenostomy.18
We hypothesized that the protective effect of aspirin on the
metaplasiaedysplasiaecarcinoma sequence in the esophagus could
be mediated through modulation of the MAP kinase pathway.
3. Materials and methods
Animals and surgical procedure: The rats used for experiments were inbred
wistar group of both sexes. They were housed in clean cages before and after the
planned experiment. A total of 56 animals were included in the study. Of these, 3were “Naive control” animals which did not undergo the surgical procedure. The
remaining animals were divided into two groups: Surgery alone (experimental) and
Surgery þ aspirin (therapy group). The rats assigned for surgery were fasted over-
night and surgeries were done under sterile techniques using intraperitoneal thio-
pentone sodium for anesthesia (75 mg/kg).
3.1. Procedure
A midline upper abdominal incision was made; the gastro esophageal junction
was identiﬁed and suture ligated ﬂush with the stomach. The distal esophagus was
then transected proximal to the ligature. An enterotomywas made 3 cm distal to the
pylorus on the anti-mesenteric border. The distal esophagus was then anastomosed
to the duodenal enterotomy with accurate mucosa to mucosa opposition. The
esophago-duodenal anastomosis was completed with six to eight interrupted full-
thickness stitches of 7-0 polypropylene (Fig. 1).
At the end of the operation, 1 ml of 0.9% sodium chloride was left in the peri-
toneal cavity. Water was permitted after the rats were recovered from anesthesia;
they were allowed to take standard solid chow ad libitum on post-operative day
[POD] 1. Rats were on a 12 h lighte12 h dark cycle at 21.6 C. If they had poor intake,
they were force fed in the immediate post-operative period. Animals were admin-
istered aspirin in the therapy group from POD 1; the brand used was disprin, the
dispersible brand of aspirin from Rickitt & Collman of [I] Ltd which has 350 mg of
acetyl salicylic acid as active ingredient. It was dissolved in their drinking water at
a dose of 6 mg per kg per day and given daily till the end of the study. They were
euthanized between 44 and 48 weeks using toxic doses of thiopentone. Then the
abdomen was opened and esophagus resected from the cervical esophagus to the
area just beyond the anastomosis in the duodenum. The specimens were examined
grossly for the presence of ulcers, nodularity or tumor. Representative sections were
taken from the lower esophagus and the tissue was routinely processed and
parafﬁn-embedded. Five micron sections were cut and stained with hematoxylin
and eosin. The slides were examined for the presence of reactive epithelial changes,
dysplasia and malignancy.
3.2. Western blot analysis
Esophageal tissues were homogenized in buffer containing 250 mM sucrose,
5 mM Hepes and 1 mM EDTA pH-7.4 with protease inhibitor cocktail consisting of
2 mM AEBSF, 1 mM EDTA, 130 mM bestatin, 14 mM E64, 1 mM leupeptin and 0.3 mM
aprotinin using a Porter eElvejhem homogenizer. Aliquots (20 mg) of esophageal
homogenates were separated on an SDS-12% polyacrylamide gel followed by
transfer onto polyvinyldine diﬂuoride (PVDF) membranes (Millipore). Membranes
were then blocked with 5% BSA in phosphate buffered saline tween-20 (PBST)
following which they were probed using the following antibodies: - anti- P44/42
MAPK, anti-phosphorylated P44/42 MAPK, anti- P38 MAPK, anti-phosphorylated
P38 MAPK, anti-VEGF Receptor 2 or anti-phospho-VEGF Receptor 2 (Cell Signaling
Technology). Following incubation with horse radish peroxidase labeled secondary
Fig. 2. Intra operative picture showing the type A esophago duodenal anastomosis. It
also demonstrates peri esophageal desmoplastic reaction along the duodenum and on
to the liver. The serosal nodules also can be visible at the anastomosis.
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West Dura substrate Pierce). Bands were then quantitated by Scion Image (Scion
Corp).
3.3. Caspase assay
Caspase 3 activity was detected in esophageal homogenates by measuring the
proteolytic cleavage of the colorimetric substrate acetyl-Asp-Glu-Val-Asp (DEVD)-
pNA in assay buffer [100 Mm Hepes, 10% sucrose, 0.1% 3-[(3-cholamidopropyl)
dimethylammonio]-1-propanesulfonate (CHAPS), pH 7.5], 1 mM phenyl-
methylsulfonyl ﬂuoride, 10 mM DTT by using the absorbance of released para-
nitroanilide at 405 nm.
3.4. Gelatin zymography
Zymogram of protease activity was performed as described,19 withmodiﬁcation.
Polyacramide gels (12%) were cast containing 0.2% gelatin. Esophageal homogenate
(10 mg protein) were applied on the gel in standard SDS loading buffer containing
0.1% SDS but lacking 2-mercaptoethanol. Protein denaturationwas not performed by
boiling the sample. The gels were run at 100 V for 2 h at 4 C and then soaked in 2%
Triton X-100 on a shaker for 11/2 h with three changes at 20 C. Following this, the
gels were soaked in reaction buffer (0.1 M TriseHCl pH 7.5) overnight at 37 C and
then stained with coomassie brilliant blue.
3.5. Protein estimation
Proteinwas estimated by the method of Lowry20 using bovine serum albumin as
standard.
3.6. Statistical analysis
Frequencies and percentages were obtained to summarize the study variables.
All categorical variables between the two study groups were compared using Fisher
exact test. A P value of less than 0.05 was considered statistically signiﬁcant.
4. Results
Peri-operative mortality was 6% and theywere due to anesthetic
and other surgery related complications. 25 rats in experimental
and 24 rats in therapy group survived through the study period. At
laparotomy, there were dense adhesions between the liver and the
anastomotic site, which was seen mostly at the left sub-hepatic
region. 60% of animals in the experimental group had dense
adhesions and sub serosal nodules (Fig. 2). Intra operatively, rats in
both groups had shown peri esophageal adhesions with the liver
and diaphragm.
Esophagus was opened longitudinally along the esophago-
duodenal anastomotic site and there were mucosal nodules of
size from<1mm to 0.8mmpresent on the esophageal mucosal and
serosal side (Fig. 3). The presence of gross mucosal nodularity was
seen in 21 and 10 rats of the experimental and therapy group
respectively (p¼ 0.03; Table 1). 11 rats in experimental group and 2
in therapy group had epithelial hyperplasia which was statistically
signiﬁcant [p < 0.01]. Papillomatosis, as shown in Fig. 4 was more
common in the experimental group (p ¼ 0.02). One rat in the
experimental group showed intestinal metaplasia; however,
adenocarcinoma was not seen. In both groups, there was a single
case of squamous cell carcinoma each (Fig. 5).
The grossly diseased esophagus was used to study the MAPK
activation in both the groups. Immuno-blots followed by densi-
tometry analysis did not show changes in protein levels of p38
[mean0.47, sd  0.64 Vs 1.07, sd  1.17, experimental and therapy
group], though levels of ERK were signiﬁcantly elevated in exper-
imental group (Fig. 6). However, treatment with aspirin had no
effect on the increased ERK protein levels (Fig. 6). Increase in
protein level per se does not indicate activation of p38 & ERK MAP
kinases, since phosphorylation of the protein is required for acti-
vation. The next series of experiments investigated the phosphor-
ylation (Fig. 7); the phosphorylated form of p38 & ERK increased
signiﬁcantly in the experimental group [mean 5.9 sd  4.3], an
effect not seen in the therapy group [P 0.01; mean, 2.73 sd  1.73].Examination of protease activity by zymographic analysis of the
esophageal samples revealed a number of gelatinolytic bands in
50% rats of the experimental group, not observed in the therapy
group. The Caspase 3 activity between the groups (Normal areas e
99.74 & nodular areas e 100.34 percent of controls, P ¼ 0.12) was
not found to be signiﬁcant. As seen in Fig. 8 and Table 1, there was
no signiﬁcant change in levels of VEGF protein or the phosphory-
lated form [mean 0.21 and 0.15, P ¼ 0.13] was evident between
experimental and therapy groups. The Naive control animals did
not show either gross or microscopic changes.
5. Discussion
Esophageal cancer is a highly aggressive cancer with increasing
incidence and mortality. Although esophageal squamous cell
carcinoma and esophageal adenocarcinoma differ in their
histology and epidemiologic distribution, some of their risk factors
(eg. dietary deﬁciencies and tobacco) and underlying mechanisms
of carcinogenesis are the same.21 A number of animal models have
been used to study esophageal reactive changes and the
progression to carcinoma. Surgery is the most commonly used
method for induction of reﬂux of duodenal contents into the
esophagus and a number of techniques have been used.5 Our
study was carried out on rats and a duodenal reﬂux model was
created with esophago duodenostomy, which had both pancreatic
and bile juices; this model was also used by many other investi-
gators.18 The mortality rate in our study was similar to other
studies but some studies demonstrated only 25% survival for rats
through the study period.22
Since the esophagus is used for temporary food storage, it has
been shown that animals usually had very severe inﬂammation
across the whole esophagus, manifested by esophageal shortening,
enlargement of the esophageal cavity (especially the lower and
middle parts), hyperkeratinization,23,24 not commonly seen in
human patients. This was relevant in our study, as there were
varying degrees of esophagitis, adhesions with the peri-esophageal
tissues and adjacent organs like diaphragm and liver.
The mutagenic effects of duodenal reﬂux in animal models are
well known to be associated with esophagitis.25,26 In the current
study, duodenal reﬂux associated mucosal changes were seen in
both groups, however changes such as gross mucosal nodularity
were signiﬁcantly less in the therapy group [P value: 0.03].
Fig. 4. Picture showing papillomatosis of the esophageal mucosa.
Fig. 3. The specimen of the esophagus which was cut opened longitudinally along
with the duodenal anastomotic site, showing the mucosal nodules.
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changes in the squamous epithelium such as basal cell hyperplasia,
squamous and glandular metaplasia. Basal cell hyperplasia was
more common in the experimental group, but this difference did
not reach statistical signiﬁcance. Epithelial hyperplasia and cysts
were also signiﬁcantly reduced in therapy group [P 0.01]. Papil-
lomatosis was seen in 15 vs 7 rats in experimental and therapy
group. Papillomatosis was characterized by basal cell hyperplasia,
papillary elongation, and hyperkeratosis which were also observed
by other investigators.21 In our study, papillomatosis and keratosis
were prevented signiﬁcantly by aspirin [P 0.02].
The duodenal reﬂuxants are typically known to produce
adenocarcinomas at the anastomosis. In our experiment, there was
only one case in each groupwith squamous cell carcinoma [SCC]. In
a study, the admixture of gastric juice with duodenal juice modu-
lated the tumorigenic effects. There was an increase in esophageal
adenocarcinoma from 30 to 87% when the gasterctomy was also
performed as part of the operation to reduce the amount gastric
juice. Speciﬁcally, the absence of gastric juice resulted in a threefold
increase in the prevalence of adenocarcinomawhereas the absence
of gastric juice did not augment squamous cancers.21 It seems that
the gastric juice has a protective role against the development of
adenocarcinoma, the common carcinoma seen in patients with
Barrett esophagus. It is also evident that SCC is independent of the
gastric juices’ effect.
In our duodenal reﬂuxmodel, the stomach was retained and the
gastric juice was allowed to have its effect at the anastomotic site
which might explain the lower incidence of carcinomas in ourTable 1
P value is signiﬁcant for p38 and phosphorylated ERK were up regulated in the
experiment group which was prevented signiﬁcantly by aspirin in therapy group.
Epithelial hyperplasis, papillomatosis and gross mucosal nodularity was signiﬁ-






Gross mucosal changes 21 10 0.03
Epithelial hyperplasia and cysts 11 2 0.01
Papillomatosis and keratosis 15 7 0.02
P38 0.0012 0.90 <0.05
Phosphorylated ERK 4.975 1.774 0.005
VEGF 0.213 0.155 P 0.13study, though the genetic nature of the rats might have also
contributed; it was beyond the scope of this paper to study that
aspect. As explained before, these reﬂuxants can still be carcino-
genic as the rats developed SCC in both the groups.
Mitogen activated protein (MAP) kinases are evolutionary
conserved enzymes connecting cell-surface receptors to critical
regulatory targets within cells. MAP kinases comprise a family of
ubiquitouseproline directed, protein serine/threonine kinases,
which participate in signal transduction pathways that control
intracellular events like embryogenesis, cell differentiation, cell
proliferation and cell death.27 The three principal MAPK compo-
nents are the extracellular regulated kinases 1 and 2 (ERK 1/2), the
c- Jun N-terminal kinase (JNK) and p38. Themain function of ERK 1/
2 is to promote cell proliferation and epithelial cell differentiation
while p38 represents a group of enzymes in the MAP kinase family
that are activated and phosphorylated on a Thr-Gly-Tyr motif and
hence involved in the signaling pathways.
The MAP kinase pathway has been implicated in the growth
and survival of a broad spectrum of human tumors.28 Increase in
ERK 1/2 activity has been demonstrated in human epidermoidFig. 5. Squamous cell carcinoma of the esophagus.
Fig. 6. 20 ug of esophageal homogenates from animals in various groups as indicated
were probed for total p38 (A) and total ERK (B) protein levels. The experiments were
carried out as detailed in the materials and methods section. The intensity of the bands
were determined and plotted as mean fold change. *p < 0.05 when compared to
controls.Representative blots showing levels of phosphorylated and total p38 and ERK
protein in esophageal tissue from animals in various groups as indicated. (B&C)
Quantiﬁcation of band intensity for phosphorylated.
Fig. 7. Representative zymogram illustrating proteases in esophageal homogenate
from animals in various groups as indicated. The experiments were carried out as
detailed in the materials and methods section.
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that conjugated bile salt exposure activates p38 and ERK MAP
kinase pathways to produce a proliferative effect in a non-
neoplastic cell line.31 Our data supports these ﬁndings and
demonstrates, for the ﬁrst time to our knowledge in a surgically-
induced duodenoesophageal reﬂux animal model, that ERK & p38
pathways are up regulated early in the process and suggest that
inhibition of this pathway was probably the mechanism by which
aspirin exerts its beneﬁcial effects. However the decrease in
phospho-protein levels in the aspirin treated groups may also
reﬂect the fact that aspirin decreased inﬂammation and subsequent
changes in phenotype. The MAP kinase ﬁndings may just be asso-
ciated with the anti-inﬂammatory effect of aspirin and may or may
not reﬂect a direct cause and effect relationship. But a study by
Zhang et al also demonstrated differences in MAPK pathways
activated by bile acid exposure in esophageal squamous cell linesand biopsies from patients with GERD12 as well. P44 was not up
regulated in our study between the groups as the mean difference
was 0.93 [t test- 0.91[95% CI 1.15e2.42].
Considerable evidence exists to indicate that matrix metal-
loproteinases (MMPs) have an important role in tumor invasion
and tumor spread.13e16 Expression of MMPs were correlated to the
progression of human esophageal squamous cell carcinoma32,33
and increased levels of MMP-2 and MMP-9 proteins in squamous
cell carcinoma as compared to normal esophageal tissues suggest
their association with esophageal tumor genesis and indicated that
these alterations may be early events in esophageal tumor
genesis.34 Our data in the animal model supports this as the
increased protease activity was visible on zymography in the
experimental (p < 0.05) and this is well demonstrated in Fig. 7.
MMPs have been shown to be induced by MAP kinases such as ERK
and p38 in ﬁbroblasts.35 Protection by aspirin against MMP
induction in our study suggests that ERK and p38 probably act
upstream of MMP induction in squamous cell carcinoma as well. In
Table 2, some specimens did not show expression of either p38 or
p44, which might reﬂect the resistant nature of the esophageal
endothelium to the reﬂuxants (Table 2). Mucosal resistance to
reﬂux in esophagus is a well-recognized phenomenon.41
Caspase 3 activity was insigniﬁcant caspase 3 between the
groups (Normal areas e 99.74 & nodular areas e 100.34 percent of
controls) suggesting that induction of apoptosis had not occurred.
Vascular endothelial growth factor [VEGF] has been suggested
to contribute to the aggressive characteristics of esophageal squa-
mous cell carcinoma and possibly correlate with tumor stage,
positive lymph nodes, and patient outcome.36,37 However, VEGF
expression can be inﬂuenced by a number of factors including type
of bile acid38 and VEGF expression in esophageal carcinomas which
varies from 30 to 40%.39,40 In our study, no change in VEGF protein
level of activation was evident in the experimental group when
Fig. 8. (A) Representative blots showing levels of phosphorylated and total VEGF
protein in esophageal tissue from animals in various groups as indicated. (B&C)
Quantitation of band intensity for protein level and phosphorylated forms of VEGF
plotted as mean fold change. The experiments were carried out as detailed in the
materials and methods section.
Table 2
Values are in fold change compared to controls for MAPK and VEGF protein
expression. The mean of these fold changes were signiﬁcant for Phophorylated p38
up regulation which was prevented by aspirin in the therapy group.
Phospho Phospho Phospho
P38 P38 P44 P44 VEGF VEGF
Experiment group 0.91 0.00 1.06 3.29 0.00 0.00
0.91 0.00 1.02 1.35 0.00 0.00
0.00 0.00 0.00 4.14 0.00 0.00
0.00 0.00 0.00 4.96 0.00 0.00
0.00 0.00 0.00 5.61 0.00 0.00
0.00 0.00 0.00 5.41 0.00 0.00
0.77 4.28 0.54 1.99 1.21 0.73
0.74 8.05 1.08 3.84 0.49 0.94
0.00 9.83 1.47 3.03 0.89 1.85
0.00 9.52 1.15 4.19 0.74 1.75
0.00 16.00 0.94 2.37 1.85 0.00
1.08 2.01 5.35 5.67 0.15 0.56
0.00 2.98 5.83 5.96 0.20 0.69
0.00 3.85 6.46 7.73 0.52 2.07
0.44 3.02 0.00 5.58 0.00 0.00
2.39 4.81 1.15 8.50 0.35 1.76
0.77 6.29 1.01 10.46 0.00 0.57
Therapy group 0.00 0.27 0.00 0.00 0.00 0.00
0.00 0.29 0.00 0.00 0.00 0.00
0.00 0.51 0.00 0.00 0.00 0.00
0.00 3.43 0.00 6.20 0.00 0.00
1.02 1.95 2.60 5.60 0.76 0.49
2.69 2.60 2.47 8.46 0.95 0.60
0.00 1.13 1.40 3.73 0.82 1.48
3.30 3.40 0.98 1.76 0.55 0.29
2.34 3.25 1.22 1.75 0.23 0.53
0.00 0.00 0.00 0.53 0.00 0.00
0.99 2.12 1.02 1.65 0.10 0.59
1.24 3.64 1.87 2.46 0.38 0.71
2.52 5.72 1.92 2.53 0.86 2.85
1.15 5.81 1.08 1.91 0.45 2.86
0.00 2.35 0.00 1.01 0.00 0.00
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0.33e0.62] which was not signiﬁcant; this could explain the low
incidence of malignancy (Fig. 8).6. Conclusion
The present study demonstrates a semi-mechanistic approxi-
mation to show that low dose of aspirin reduces the incidence of
duodenoesophageal reﬂux induced histological changes in the
esophagus by preventing activation of proliferative & anti-
apoptotic MAP kinases such as p38 & ER as well as protease
activity. Though Barretts’ changes and adenocarcinoma have not
developed, it could explain the role of duodenoesophageal reﬂux in
the development of different histological but potential premalig-
nant lesions and molecular level changes which are prevented by
low dose aspirin.
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